Review



biotinylated anti mouse cd39 antibody  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Miltenyi Biotec biotinylated anti mouse cd39 antibody
    Biotinylated Anti Mouse Cd39 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/CD39+Antibody%2C+anti-mouse%2C+REAfinity/pm41216948-48-13-20
    Average 93 stars, based on 7 article reviews
    biotinylated anti mouse cd39 antibody - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: TGF-β and IL-12 conversely orchestrate the formation of CD103 + CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine
    Article Snippet: anti-mouse CD39-APC (REA870/24DMS1) , Miltenyi , Cat#130-114-358; RRID: AB_2726584.

    Clinical Proteomics:

    Article Title: TACI is required for the survival of short- and long-lived plasma cells.
    Article Snippet: In a typical immune response, naïve B cells are activated, differentiated into short-lived plasma cells (SLPCs), and then matured into long-lived plasma cells (LLPCs) in the bone marrow.. Among three TNF family receptors (BAFF-R, TACI, and BCMA), BAFF-R and BCMA are known to be crucial for the maintenance of naïve B cells and bone marrow LLPCs, respectively.. In contrast, the function of TACI remains unclear, as analysis of global TACI knockout mice suggests the existence of two opposing roles in B and plasma cells.

    Selection:

    Article Title: TACI is required for the survival of short- and long-lived plasma cells.
    Article Snippet: In a typical immune response, naïve B cells are activated, differentiated into short-lived plasma cells (SLPCs), and then matured into long-lived plasma cells (LLPCs) in the bone marrow.. Among three TNF family receptors (BAFF-R, TACI, and BCMA), BAFF-R and BCMA are known to be crucial for the maintenance of naïve B cells and bone marrow LLPCs, respectively.. In contrast, the function of TACI remains unclear, as analysis of global TACI knockout mice suggests the existence of two opposing roles in B and plasma cells.

    Immunopeptidomics:

    Article Title: Defining the activity of pro-reparative extracellular vesicles in wound healing based on miRNA payloads and cell type-specific lineage mapping
    Article Snippet: .. Antibodies NAME SOURCE CATALOG # CD9-PE (mouse) Miltenyi Biotec Cat# 130-123-052 CD81-PE (mouse) Miltenyi Biotec Cat# 130-102-632 CD63-PE (mouse) Miltenyi Biotec Cat# 130-123-289 MHC class I-PE (mouse) Biolegend Cat# 114607 CD29-PE (mouse) Miltenyi Biotec Cat# 130-119-165 CD274(PD-L1)-PE (mouse) Biolegend Cat# 124307 CD39-PE (mouse) Miltenyi Biotec Cat# 130-114-357 CD44-PE (mouse) Miltenyi Biotec Cat# 130-118-694 CD45-PE (mouse) Miltenyi Biotec Cat# 130-110-797 CD11b-PE (mouse) Miltenyi Biotec Cat# 130-113-806 CD54(ICAM-1)-PE (mouse) Miltenyi Biotec Cat# 130-104-214 CD49e-PE (mouse) Miltenyi Biotec Cat# 130-122-072 CD24-PE (mouse) Miltenyi Biotec Cat# 130-110-826 CD126(IL-6R)-PE (mouse) Biolegend Cat# 115806 CD66a-PE (mouse) Miltenyi Biotec Cat# 130-125-525 CD326(Ep-CAM)-PE (mouse) Biolegend Cat# 118205 Isotype-PE Miltenyi Biotec Cat# 130-113-450 Anti-Alix (E6P9B) mAb (mouse) Cell signaling Cat# 92880 Anti-CD9 (mouse) Thermo Fisher Cat# PA5-85955 Anti-CD81 (D5O2Q) (mouse) Cell signaling Cat# 10037 Anti-CD63 (mouse) Thermo Fisher Cat# PA5-92370 Anti-FLAG antibody Sigma Aldrich Cat# F-1804 Anti-mouse IgG, HRP-linked antibody Cell signaling Cat# 7076 Anti-rabbit IgG, HRP-linked antibody Cell signaling Cat# 7074 Anti-Rabbit HRP Polymer Cell IDX Cat# 2RH-100 Ki-67 Rabbit monoclonal Antibody (1:50) GeneTex Cat# 16667 Vimentin (D21H3) mAb Cell signaling Cat# 5741 Goat anti-Rabbit IgG-Alexa Fluor 546 Thermo Fisher Cat# A11010 Goat anti-Mouse IgG-Alexa Fluor 546 Thermo Fisher Cat# A11030 Anti-FLAG-vTagTM Antigody Cellarcus Biosciences Cat# CBS18-PE-100T Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa FluorTM 488 Thermo Fisher Cat# A-11008 ApoE Cell signaling Cat#49285 Table S7. ..

    Polymer:

    Article Title: Defining the activity of pro-reparative extracellular vesicles in wound healing based on miRNA payloads and cell type-specific lineage mapping
    Article Snippet: .. Antibodies NAME SOURCE CATALOG # CD9-PE (mouse) Miltenyi Biotec Cat# 130-123-052 CD81-PE (mouse) Miltenyi Biotec Cat# 130-102-632 CD63-PE (mouse) Miltenyi Biotec Cat# 130-123-289 MHC class I-PE (mouse) Biolegend Cat# 114607 CD29-PE (mouse) Miltenyi Biotec Cat# 130-119-165 CD274(PD-L1)-PE (mouse) Biolegend Cat# 124307 CD39-PE (mouse) Miltenyi Biotec Cat# 130-114-357 CD44-PE (mouse) Miltenyi Biotec Cat# 130-118-694 CD45-PE (mouse) Miltenyi Biotec Cat# 130-110-797 CD11b-PE (mouse) Miltenyi Biotec Cat# 130-113-806 CD54(ICAM-1)-PE (mouse) Miltenyi Biotec Cat# 130-104-214 CD49e-PE (mouse) Miltenyi Biotec Cat# 130-122-072 CD24-PE (mouse) Miltenyi Biotec Cat# 130-110-826 CD126(IL-6R)-PE (mouse) Biolegend Cat# 115806 CD66a-PE (mouse) Miltenyi Biotec Cat# 130-125-525 CD326(Ep-CAM)-PE (mouse) Biolegend Cat# 118205 Isotype-PE Miltenyi Biotec Cat# 130-113-450 Anti-Alix (E6P9B) mAb (mouse) Cell signaling Cat# 92880 Anti-CD9 (mouse) Thermo Fisher Cat# PA5-85955 Anti-CD81 (D5O2Q) (mouse) Cell signaling Cat# 10037 Anti-CD63 (mouse) Thermo Fisher Cat# PA5-92370 Anti-FLAG antibody Sigma Aldrich Cat# F-1804 Anti-mouse IgG, HRP-linked antibody Cell signaling Cat# 7076 Anti-rabbit IgG, HRP-linked antibody Cell signaling Cat# 7074 Anti-Rabbit HRP Polymer Cell IDX Cat# 2RH-100 Ki-67 Rabbit monoclonal Antibody (1:50) GeneTex Cat# 16667 Vimentin (D21H3) mAb Cell signaling Cat# 5741 Goat anti-Rabbit IgG-Alexa Fluor 546 Thermo Fisher Cat# A11010 Goat anti-Mouse IgG-Alexa Fluor 546 Thermo Fisher Cat# A11030 Anti-FLAG-vTagTM Antigody Cellarcus Biosciences Cat# CBS18-PE-100T Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa FluorTM 488 Thermo Fisher Cat# A-11008 ApoE Cell signaling Cat#49285 Table S7. ..

    Centrifugation:

    Article Title: Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy
    Article Snippet: .. After centrifugation, 5*10 6 cells were transferred to FACS tube, washed again with RPMI, and stained with the following antibodies: Anti-CD8a-BUV 737 (clone 53-6.7, Invitrogen, Cat. 367-0081) Anti-CD4-Vio Blue (clone REA604, Miltenyi Biotech, Cat. 130-118-696) Anti-CD137-PE-Vio 615 (clone REA936, Miltenyi Biotech, Cat. 130-115-572) Anti-Granzyme B-PE-FITC (clone REA226, Miltenyi Biotech, Cat. 130-118-480) Anti-CD44-APC-Vio779 (clone REA664, Miltenyi Biotech, Cat. 130-118-695) Anti-CD62L-PerCP-Vio700 (clone REA828, Miltenyi Biotech, Cat. 130-112-840) Anti-CD39-APC (clone REA870, Miltenyi Biotech, Cat. 130-114-359) Anti-FoxP3-PE (clone REA788, Miltenyi Biotech, Cat. 130-111-678) Zombie-UV (Biolegend, Cat. 423107). ..

    FACS:

    Article Title: Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy
    Article Snippet: .. After centrifugation, 5*10 6 cells were transferred to FACS tube, washed again with RPMI, and stained with the following antibodies: Anti-CD8a-BUV 737 (clone 53-6.7, Invitrogen, Cat. 367-0081) Anti-CD4-Vio Blue (clone REA604, Miltenyi Biotech, Cat. 130-118-696) Anti-CD137-PE-Vio 615 (clone REA936, Miltenyi Biotech, Cat. 130-115-572) Anti-Granzyme B-PE-FITC (clone REA226, Miltenyi Biotech, Cat. 130-118-480) Anti-CD44-APC-Vio779 (clone REA664, Miltenyi Biotech, Cat. 130-118-695) Anti-CD62L-PerCP-Vio700 (clone REA828, Miltenyi Biotech, Cat. 130-112-840) Anti-CD39-APC (clone REA870, Miltenyi Biotech, Cat. 130-114-359) Anti-FoxP3-PE (clone REA788, Miltenyi Biotech, Cat. 130-111-678) Zombie-UV (Biolegend, Cat. 423107). ..

    Staining:

    Article Title: Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy
    Article Snippet: .. After centrifugation, 5*10 6 cells were transferred to FACS tube, washed again with RPMI, and stained with the following antibodies: Anti-CD8a-BUV 737 (clone 53-6.7, Invitrogen, Cat. 367-0081) Anti-CD4-Vio Blue (clone REA604, Miltenyi Biotech, Cat. 130-118-696) Anti-CD137-PE-Vio 615 (clone REA936, Miltenyi Biotech, Cat. 130-115-572) Anti-Granzyme B-PE-FITC (clone REA226, Miltenyi Biotech, Cat. 130-118-480) Anti-CD44-APC-Vio779 (clone REA664, Miltenyi Biotech, Cat. 130-118-695) Anti-CD62L-PerCP-Vio700 (clone REA828, Miltenyi Biotech, Cat. 130-112-840) Anti-CD39-APC (clone REA870, Miltenyi Biotech, Cat. 130-114-359) Anti-FoxP3-PE (clone REA788, Miltenyi Biotech, Cat. 130-111-678) Zombie-UV (Biolegend, Cat. 423107). ..



    Similar Products

    93
    Miltenyi Biotec cd39 antibody, anti-human
    Cd39 Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/CD39+Antibody%2C+anti-human/custom%40130-125-113%4042526444
    Average 93 stars, based on 1 article reviews
    cd39 antibody, anti-human - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Sino Biological cd39 entpd1
    Cd39 Entpd1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/Mouse+CD39+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-HA+tag/pmc13051965-841-0-9
    Average 94 stars, based on 1 article reviews
    cd39 entpd1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cd39 inhibitor arl 67156 trisodium salt
    Cd39 Inhibitor Arl 67156 Trisodium Salt, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/ARL67156+trisodium/pm42873856-764-5-11
    Average 94 stars, based on 1 article reviews
    cd39 inhibitor arl 67156 trisodium salt - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    R&D Systems cd39 ax700
    Cd39 Ax700, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/Human+CD39%2FENTPD1+Alexa+Fluor%C2%AE+700-conjugated+Antibody/pm42822324-60-35-37
    Average 94 stars, based on 1 article reviews
    cd39 ax700 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec anti foxp3 pe
    Anti Foxp3 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/CD39+Antibody%2C+anti-mouse%2C+REAfinity/pmc13365579-526-72-75
    Average 93 stars, based on 1 article reviews
    anti foxp3 pe - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec ‒ anti cd39 apc
    ‒ Anti Cd39 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/CD62L+Antibody%2C+anti-mouse%2C+REAfinity/pm42098128-440-70-74
    Average 93 stars, based on 1 article reviews
    ‒ anti cd39 apc - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    fluidigm anti human cd39 a1 160gd
    Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of <t>CD39</t> and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.
    Anti Human Cd39 A1 160gd, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/Anti-Human+CD39+(A1)-160Gd/pmc13006393-86-0-5
    Average 93 stars, based on 1 article reviews
    anti human cd39 a1 160gd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    fluidigm 3160004b
    Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of <t>CD39</t> and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.
    3160004b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/Anti-Human+CD39+(A1)-160Gd/pmc13006393-86-9-5
    Average 93 stars, based on 1 article reviews
    3160004b - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Bio-Rad mouse anti human cd39
    Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of <t>CD39</t> and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.
    Mouse Anti Human Cd39, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/Mouse+anti+Human+CD39/us12569592-1790-3-8
    Average 94 stars, based on 1 article reviews
    mouse anti human cd39 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec biotinylated anti mouse cd39 antibody
    Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of <t>CD39</t> and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.
    Biotinylated Anti Mouse Cd39 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd39/CD39+Antibody%2C+anti-mouse%2C+REAfinity/pm41216948-48-13-20
    Average 93 stars, based on 1 article reviews
    biotinylated anti mouse cd39 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of CD39 and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.

    Journal: Cell Reports Medicine

    Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial

    doi: 10.1016/j.xcrm.2026.102638

    Figure Lengend Snippet: Phenotypic modulation of T cells and enhanced priming by anti-CTLA4-NF (A) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD8 T cells by CyTOF. Clusters were derived from FlowSOM. (B) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (C) Expression of CD39 and 4-1BB by geometric MI on CD8 T cells as represented by color mapping on PaCMAP plot. (D) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. For this and all violin plots to follow, solid lines denote group medians, while dashed lines denote quartiles. (E) PaCMAP plot of NeoRED-P patient tumor-infiltrating CD4 + FoxP3 - Tconv cells by CyTOF. Clusters were derived from FlowSOM. (F) Pseudocolor density plots of CD4 Tconv cells in PaCMAP space stratified by treatment group. (G) Expression of CD39 and 4-1BB by geometric MI on CD4 Tconv as represented by color mapping on PaCMAP plot. (H) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD4 Tconv cells as a percentage of all CD8 T cells stratified by treatment group. Untreated, n = 7; ADT, n = 8; ADT + anti-CTLA4-NF, n = 8. Single patient with MSI hi status called out in plot. (I) PaCMAP plot of MycCaP-infiltrating CD8 T cells by 45-parameter flow cytometry in response to ADT, ADT + anti-CTLA4 (ND), or ADT + anti-CTLA4 (D). Clusters were derived from FlowSOM. (J) Pseudocolor density plots of CD8 T cells in PaCMAP space stratified by treatment group. (K) Expression of CD39 and 4-1BB by geometric MFI on CD8 T cells as represented by color mapping on PaCMAP plot. (L) Violin plot representing frequency of manually gated CD39 + 4-1BB + CD8 T cells as a percentage of all CD8 T cells stratified by treatment group. (M) Biaxial plots representing expression of CD44 and Ki67 on CD8 T cells in tumor-draining lymph nodes of mice shown in (I–L). (N) Biaxial plots representing expression of CD44 and Ki67 on CD4 + FoxP3 − Tconv cells in tumor-draining lymph nodes of mice shown in (L–O). (O) Violin plots representing frequencies of CD44 + Ki67 + CD8 and CD4 Tconv cells as a percentage of parent populations stratified by treatment group. Two-tailed Welch’s t test was used to assess statistical significance. All murine data shown are n = 7 per group and representative of two independent experiments each for survival and immune profiling studies.

    Article Snippet: Anti-Human CD39 (A1) 160Gd , Standard BioTools , Cat# 3160004B.

    Techniques: Derivative Assay, Expressing, Flow Cytometry, Two Tailed Test